About Clinigen Group (OTCMKTS:CLIGF)
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Annual Sales$383.41 million
Price / Sales4.43
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Clinigen Group (OTCMKTS:CLIGF) Frequently Asked Questions
What is Clinigen Group's stock symbol?
Clinigen Group trades on the OTCMKTS under the ticker symbol "CLIGF."
Who are some of Clinigen Group's key competitors?
Some companies that are related to Clinigen Group include ELEKTA (EKTAY), ABLYNX (ABLYF), Neogen (NEOG), Acadia Healthcare (ACHC), Healthequity (HQY), Udg Healthcare (UDHCF), China Biologic Products (CBPO), AnaptysBio (ANAB), Evotec (EVTCY), Inogen (INGN), Magellan Health (MGLN), Nevro (NVRO), Merit Medical Systems (MMSI), argenx SE - American Depositary Shares (ARGX), The Medicines (MDCO), Emergent Biosolutions (EBS), LifePoint Health (LPNT) and Omnicell (OMCL).
How do I buy Clinigen Group stock?
Shares of Clinigen Group can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Clinigen Group's stock price today?
One share of Clinigen Group stock can currently be purchased for approximately $13.90.
How big of a company is Clinigen Group?
Clinigen Group has a market capitalization of $1.60 billion and generates $383.41 million in revenue each year. Clinigen Group employs 465 workers across the globe.
How can I contact Clinigen Group?
Clinigen Group's mailing address is PITCAIRN HOUSE CROWN SQUARE FIRST AVENUE, STAFFORDSHIRE X0, D E14 2W W. The company can be reached via phone at 01283 495010.
MarketBeat Community Rating for Clinigen Group (CLIGF)MarketBeat's community ratings are surveys of what our community members think about Clinigen Group and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Clinigen Group (OTCMKTS:CLIGF) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Earnings History for Clinigen Group (OTCMKTS:CLIGF)
No earnings announcements for this company have been tracked by MarketBeat.com
Clinigen Group (OTCMKTS:CLIGF) Earnings Estimates
Current Year EPS Consensus Estimate: $0.63 EPS
Next Year EPS Consensus Estimate: $0.69 EPS
Dividend History for Clinigen Group (OTCMKTS:CLIGF)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Clinigen Group (OTCMKTS CLIGF)
No insider trades for this company have been tracked by MarketBeat.com
Clinigen Group (OTCMKTS CLIGF) News Headlines
Clinigen Group (OTCMKTS:CLIGF) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Clinigen Group (OTCMKTS CLIGF) Stock Chart for Wednesday, January, 17, 2018